A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease.
about
Thyroid Growth and CancerMediator kinase module and human tumorigenesisTumor and stromal-based contributions to head and neck squamous cell carcinoma invasionGenomic profiling reveals mutational landscape in parathyroid carcinomasCarbon dating cancer: defining the chronology of metastatic progression in colorectal cancerConstruction of a pathological risk model of occult lymph node metastases for prognostication by semi-automated image analysis of tumor budding in early-stage oral squamous cell carcinoma.Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutationsMALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9.Unraveling the molecular genetics of head and neck cancer through genome-wide approachesMolecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.Personalized targeted therapy for esophageal squamous cell carcinoma.Stably Expressed Genes Involved in Basic Cellular Functions.mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer.AKAP-9 promotes colorectal cancer development by regulating Cdc42 interacting protein 4.Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity CancersQuantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis.Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention.Genomic analysis to define molecular basis of aggressiveness in a mouse model of oral cancer.Frameshift Mutations of AKAP9 Gene in Gastric and Colorectal Cancers with High Microsatellite Instability.Staging of early lymph node metastases with the sentinel lymph node technique and predictive factors in T1/T2 oral cavity cancer: A retrospective single-center study.The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer.Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade.The Mouse Tumor Biology Database: A Comprehensive Resource for Mouse Models of Human Cancer.Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT.Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma.Expressional analysis of disease-relevant signalling-pathways in primary tumours and metastasis of head and neck cancers.Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms.Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies.WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapyAntagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer
P2860
Q26777603-18A54C05-7A49-427E-9EC1-57988CC9079CQ26800203-0BB7FBF8-D812-4540-87EE-D3BB1D7DF4F0Q26825164-7EA205C4-51EE-4B02-AEF4-AF814D2006DFQ30360213-F941EF65-1236-438B-A856-CBACE203CFD8Q30854226-E685AA97-2080-4E9A-BA3A-FDF1095AB271Q33566888-C8DC5068-1269-4FF8-97A6-6FA14C7A9FF5Q34549536-79221968-E7BD-4156-A6D8-678F44CA2E8DQ34718248-193F916D-7B5D-4630-B615-C58A190320F8Q35025009-0010DF08-876E-413F-BAFC-CF2D40203BFDQ35618225-05189653-EB38-4C05-84A9-DC75E1E720F8Q35819517-6E8C0871-593C-4DDC-80A3-4B8BA3F27FF3Q36261258-0A4E51F0-9198-4B75-8B85-5E2BEEA2A336Q36546669-4922F70C-FF89-4C78-AC3D-55D2D9B2E595Q36839866-D074D801-5ADA-447E-9083-CBC46443099AQ37059878-13A81743-71FC-4092-BD2A-88F61B284D75Q37148314-52316768-E3FB-4202-B68A-004A2EC1A6D6Q37689082-0D3B1878-C433-4D59-972D-36D08EF999D5Q38653658-34BEC1D2-CAFD-4DFE-ACB7-F3E13B771BEAQ38850128-428C2D07-0E51-4100-994D-BF81A992437AQ38904737-E7916211-6F6F-4D2D-AD62-5EB423C48537Q40086629-8976D698-D144-4909-84BC-4D7159938C50Q40872827-315848FB-3F09-4EB9-9C9B-8505848E0045Q41667207-596FFBD0-E289-4C95-A547-7321C2AFC719Q47391699-1DD7D9E8-5FFE-4284-93D9-97BAD98ADC2AQ47564965-864CDAC6-DE69-428E-ABDA-C0A85BD9C704Q47964921-8A20DE4B-7FE9-45B6-AE50-E9BB352F406AQ49638561-9CACC5DC-5938-4E17-98EA-BC63B593A0ADQ54979438-B25EDE7A-0B04-4EC1-B7E7-B1F267D665CFQ55274460-B582FFBD-8C2A-4823-A67B-7F6D50DF1C62Q55493323-580FE088-5CEA-4D88-A102-E298D2D25D14Q57138889-FF401001-27DC-49B8-9727-33F3BC974A11Q58567297-8E4ACF8C-FE7F-40C2-8A26-2904417E2322
P2860
A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A surprising cross-species con ...... predicting metastatic disease.
@en
type
label
A surprising cross-species con ...... predicting metastatic disease.
@en
prefLabel
A surprising cross-species con ...... predicting metastatic disease.
@en
P2093
P2860
P1476
A surprising cross-species con ...... predicting metastatic disease
@en
P2093
Ashley E Winkler
Charles G Rickert
Dorina Kallogjeri
Elaine R Mardis
Gavin P Dunn
James S Lewis
Jay F Piccirillo
Jonathan H Law
Krishna-Latha Kanchi
Nancy P Judd
P2860
P304
P356
10.1158/1078-0432.CCR-14-0205
P407
P577
2014-03-25T00:00:00Z